Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development? (Q37644608)

From Wikidata
Jump to navigation Jump to search
scientific article published on 02 December 2009
edit
Language Label Description Also known as
English
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
scientific article published on 02 December 2009

    Statements

    Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development? (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit